I was thinking the same, its been nearly a month and half since the first cohort 4 infusion, and w/o much news or activity on progress nor any other drug infusion on subjects, you begin to wonder what could have happened, maybe the drug was too strong which did not support safety or maybe it was worse and the patient died. Good news, if any, should come out on progress considering the study to be completed in next 4 months.
It is bleeding slowly. Seems like we may not see a ride up until markman hearing is rescheduled. Also, it will be interesting to see how FB replies end of this week, not sure if the price will further bleed with their attacks. Does not look good in my opinion. On the plus side DSS has a strong core business and has received lots of attention, the downside will be minimum if investors are willing to be patience and take each dip as buying opportunity, at the end when things ramp up investors will be awarded.
$3 will give a market cap of 15M, is this what the management values their company? They have RedChip pumping the #$%$ out of SNTI, i have a feeling that we may witness a run up to $7-8 going to the cohort 4 results mid year mostly due to some pumping of SA authors and RedChip.
I understand SNTI is very undervalued with a current market cap of only 20M. The risk/reward ratio is quite high, and we all know this can triple, quadruple or even go beyond if the results are promising from the Cohort 4, which is to be expected within the next 5-6 months. However, I am not understanding why the market is not interested. Is it because of the fear of dilution or uncertainty with the merger of Fabrus? From the presentation, it seems that they have enough cash until the year end and also Fabrus has a very extensive pipeline that will add more value to the company. I just find it hard to believe why we are at right now. Can someone here shed light? Thanks.
Mr Pig, it is $4 (four dollars) per share price in 12 months, not .04. I think a mad dog with rabies has bitten you, which is why you have been going crazy. Do us a favor, if you hate the company and management, just walk out, no reason for you to be here and make derogatory remarks, end of story. Merry Xmas, and don't forget to get vaccinated, rabies is treatable.
Yes, Mr Pig, we get it, you are one heck of a greedy pig. Keep the bashing alive so you can buy cheaper. Your J Napodana will be writing an article soon and he will raise the PT.
You hit the nail, my friend, Braeburn will buyout the company. It may not be a lot, but should easily be bought for 200M.
Mr Pig - I know you are in a mission trying to scare off some novice investors. You want to collect some cheap shares don't you? After all, you are a greedy pig, merry xmas.
Nope, this will start soaring once TTNP designs the clinical study. It has bottomed down at 0.57-0.58, approached oversold territory. Expect some analyst pumping the stock in the next week or two. Target price 1.50 within 6 months.